- Lobbying
- Michelle AND Mathy
Lobbying Arrangements Results for 'Michelle Mathy'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues regarding the availability and pricing of prescription drugs. |
EMD Serono, Inc.
|
Capitol Counsel, LLC | |||
Details Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security. |
Tempus Labs, Inc.
|
Capitol Counsel LLC | |||
Details Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H... |
Ambulatory Surgery Center Association (ASCA)
|
Capitol Counsel LLC | |||
Details Legislative and regulatory issues related to emergency medicine, including surprise medical billing, mental health, Medicare payment, and coronavirus response efforts. |
American College of Emergency Physicians
|
Capitol Counsel, LLC | |||
Details Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.29... |
Lundbeck Pharmaceuticals LLC
|
Capitol Counsel LLC | |||
Details Advocacy on health care workforce policy. |
FIGS
|
Capitol Counsel LLC | |||
Details Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and tr... |
Neurocrine Biosciences, Inc.
|
Capitol Counsel LLC | |||
Details Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. |
GlaxoSmithKline LLC
|
Capitol Counsel LLC | |||
Details Legislative and regulatory issues related to independent pharmacists. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act. |
National Community Pharmacists Association (NCPA)
|
Capitol Counsel, LLC | |||
Details Access to Prescription Digital Therapeutics Act (S.723/HR 1458). Due Process Continuity of Care Act (S. 971). Implementation of the Inflation Reduction Act. Issues related to Medicare Part D redesi... |
Otsuka America Pharmaceutical, Inc.
|
in-house lobbying | |||
Details To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023. |
Blue Earth Diagnostics, Inc.
|
Capitol Counsel, LLC | |||
Details Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023. |
Medical Imaging & Technology Alliance (MITA)
|
Capitol Counsel LLC | |||
Details Health care reform issues; legislative issues related to Title X family planning funding. Legislative issues related to judicial nominations. Provisions related to FY 2024 appropriations legislatio... |
Planned Parenthood Federation of America, Inc
|
Capitol Counsel LLC | |||
Details Advice and advocacy regarding pension funding. Advice and advocacy related to the eligibility of non-profit organizations under the Main Street Lending Program. Advice and advocacy related to the e... |
March of Dimes Inc.
|
Capitol Counsel, LLC | |||
Details Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage. Issues related to drug pricing. Package Inserts/E-Labeling Issues (H.R. 1503 Prescription... |
Merck & Company, Inc.
|
Capitol Counsel LLC | |||
Details Issues related to Medicare Part D and prescription drug pricing and patient access, including monitor implementation of related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 11... |
Astellas Pharma US, Inc.
|
Capitol Counsel, LLC | |||
Details Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage. Medicaid coverage issues. Legislative and regulatory issues affect... |
Biotechnology Industry Organization
|
Capitol Counsel LLC | |||
Details Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality ... |
Physician-Led Healthcare for America (formerly Physician Hospitals of America)
|
Capitol Counsel, LLC | |||
Details Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan cover... |
BIOGEN
|
in-house lobbying | |||
Details Legislative issues related to access to pharmaceuticals; Rebates in Medicaid and for dual-eligibles; Medicaid coverage issues; 340B Drug Program; Medicare Part B and D prescription drug reimburseme... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Capitol Counsel LLC | |||
Details Medicare sequester, PAYGO H.R. 2474, Strengthening Medicare for Patients and Providers Act: an annual inflation adjustment to Medicare physician payments S. 1512, CONNECT for Health Act of 2021: T... |
American Society of Anesthesiologists
|
in-house lobbying | |||
Details Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer and cosmetic procedures, including over the counter approval of sunscreen ingredients; legislat... |
American Academy of Dermatology
|
Capitol Counsel LLC | |||
Details Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicia... |
American Academy of Ophthalmology
|
Capitol Counsel LLC | |||
Details Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased tra... |
American Academy of Dermatology Association
|
in-house lobbying |